Mankind Pharma on Monday announced that one of its subsidiaries acquires a majority stake in Upakarma Ayurveda, an ayurvedic and herbal product D2C brand.

Mankind Pharma’s decision to invest in Upakarma Ayurveda will power a wider range of products and offerings and penetrate the market leveraging the strong distribution network of Mankind Pharma.

On the occasion, Rajeev Juneja, the Vice Chairman and Managing Director of Mankind Pharma said, “The current lifestyle has become strenuous where people find it difficult to focus on their health. As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the emerging needs of consumers.”.

Vishal Kaushik the Founder and MD, Upakarma Ayurveda said, “There has been a rising consciousness around Ayurveda in recent years. With this partnership, I along with my co-founder, Parag Kaushik, are hopeful that quality ayurvedic solutions will reach far and wide”.

Upakarma Ayurveda has repositioned Shilajit as a health and wellness product, and sought to reimagine the stereotypical way Shilajit was perceived in the market as an aphrodisiac (sexual wellness product) for men.